The Heads of Medicines Agencies (HMA) is a network of the heads of the 'national competent authorities', the agencies responsible for the regulation of human and veterinary medicines in the individual countries of the European Economic Area.
The HMA works to foster an effective and efficient European medicines regulatory system. It is supported by working groups covering specific areas of responsibility and by the Heads of Medicines Agencies Management Group and Permanent Secretariat.
The European Medicines Agency is a member of the HMA. It works with the other members on these key activities:
- addressing key strategic issues for the European medicines regulatory network, such as the exchange of information and sharing of best practice;
- collectively, being responsible for all areas of medicines regulation, including the mutual-recognition and decentralised procedures;
- focusing on the development, co-ordination and consistency of the European medicines regulatory system;
- supporting the network by providing high-quality professional and scientific resources;
- providing a focus for making the most effective use of scarce resources across the network, such as developing and overseeing arrangements for work-sharing.
EU Network Training Centre
One of the EMA/HMA Joint initiatives is the EU Network Training Centre (EU NTC), whose mission is to ensure that good scientific and regulatory practice is spread across the European medicines regulatory network along with harmonised training standards, through the provision of high quality and relevant training materials identified and shared through the EU NTC platform. Christa Wirthumer-Hoche (HMA) and Zaide Frias (EMA) were nominated as co-chairs for this initiative. For more information see the Heads of Medicines Agencies website.
How useful is this page?
Average rating:Based on 16 ratings
Add your rating:
- See all ratings
9 ratings3 ratings1 ratings1 ratings2 ratings